BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29032374)

  • 1. The ALPPS Approach for Colorectal Liver Metastases: Impact of KRAS Mutation Status in Survival.
    Serenari M; Alvarez FA; Ardiles V; de Santibañes M; Pekolj J; de Santibañes E
    Dig Surg; 2018; 35(4):303-310. PubMed ID: 29032374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.
    Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S
    Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results.
    Björnsson B; Sparrelid E; Røsok B; Pomianowska E; Hasselgren K; Gasslander T; Bjørnbeth BA; Isaksson B; Sandström P
    Eur J Surg Oncol; 2016 Apr; 42(4):531-7. PubMed ID: 26830731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: A case-matched comparison with palliative systemic therapy.
    Olthof PB; Huiskens J; Wicherts DA; Huespe PE; Ardiles V; Robles-Campos R; Adam R; Linecker M; Clavien PA; Koopman M; Verhoef C; Punt CJ; van Gulik TM; de Santibanes E
    Surgery; 2017 Apr; 161(4):909-919. PubMed ID: 28038862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.
    Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM
    JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy in the Treatment of Colorectal Liver Metastases: Current Scenario.
    Lang H; Baumgart J; Mittler J
    Dig Surg; 2018; 35(4):294-302. PubMed ID: 29621745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases?
    Hernandez-Alejandro R; Bertens KA; Pineda-Solis K; Croome KP
    Surgery; 2015 Feb; 157(2):194-201. PubMed ID: 25282528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indicating ALPPS for Colorectal Liver Metastases: A Critical Analysis of Patients in the International ALPPS Registry.
    Schnitzbauer AA; Schadde E; Linecker M; Machado MA; Adam R; Malago M; Clavien PA; de Santibanes E; Bechstein WO
    Surgery; 2018 Sep; 164(3):387-394. PubMed ID: 29803563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.
    Lahti SJ; Xing M; Zhang D; Lee JJ; Magnetta MJ; Kim HS
    J Vasc Interv Radiol; 2015 Aug; 26(8):1102-11. PubMed ID: 26210240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
    Moris D; Ronnekleiv-Kelly S; Kostakis ID; Tsilimigras DI; Beal EW; Papalampros A; Dimitroulis D; Felekouras E; Pawlik TM
    World J Surg; 2018 Mar; 42(3):806-815. PubMed ID: 28798996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients.
    Gholami S; Kemeny NE; Boucher TM; Gönen M; Cercek A; Kingham TP; Balachandran V; Allen P; DeMatteo R; Drebin J; Jarnagin W; D'Angelica M
    Ann Surg; 2020 Aug; 272(2):352-356. PubMed ID: 32675549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases.
    Adam R; Imai K; Castro Benitez C; Allard MA; Vibert E; Sa Cunha A; Cherqui D; Baba H; Castaing D
    Br J Surg; 2016 Oct; 103(11):1521-9. PubMed ID: 27517369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
    Margonis GA; Buettner S; Andreatos N; Sasaki K; Ijzermans JNM; van Vugt JLA; Pawlik TM; Choti MA; Cameron JL; He J; Wolfgang CL; Weiss MJ
    Ann Surg; 2017 Oct; 266(4):641-649. PubMed ID: 28657938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy.
    Ratti F; Schadde E; Masetti M; Massani M; Zanello M; Serenari M; Cipriani F; Bonariol L; Bassi N; Aldrighetti L; Jovine E
    Ann Surg Oncol; 2015; 22(6):1933-42. PubMed ID: 25564160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate-term survival and quality of life outcomes in patients with advanced colorectal liver metastases undergoing associating liver partition and portal vein ligation for staged hepatectomy.
    Wanis KN; Ardiles V; Alvarez FA; Tun-Abraham ME; Linehan D; de Santibañes E; Hernandez-Alejandro R
    Surgery; 2018 Apr; 163(4):691-697. PubMed ID: 29203284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management.
    Truant S; Scatton O; Dokmak S; Regimbeau JM; Lucidi V; Laurent A; Gauzolino R; Castro Benitez C; Pequignot A; Donckier V; Lim C; Blanleuil ML; Brustia R; Le Treut YP; Soubrane O; Azoulay D; Farges O; Adam R; Pruvot FR;
    Eur J Surg Oncol; 2015 May; 41(5):674-82. PubMed ID: 25630689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of associating liver partition and portal vein ligation for staged hepatectomy in colorectal liver metastases: a review.
    Hasselgren K; Sandström P; Björnsson B
    World J Gastroenterol; 2015 Apr; 21(15):4491-8. PubMed ID: 25914457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associating Liver Partition and Portal Vein Ligation for Primary Hepatobiliary Malignancies and Non-Colorectal Liver Metastases.
    Björnsson B; Sparrelid E; Hasselgren K; Gasslander T; Isaksson B; Sandström P
    Scand J Surg; 2016 Sep; 105(3):158-62. PubMed ID: 26929296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.